Found: 76
Select item for more details and to access through your institution.
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
- By:
- Publication type:
- Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
- By:
- Publication type:
- Article
Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1245, doi. 10.1002/ajh.25234
- By:
- Publication type:
- Article
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 232, doi. 10.1002/ajh.24627
- By:
- Publication type:
- Article
Autoimmune diseases and myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. E280, doi. 10.1002/ajh.24333
- By:
- Publication type:
- Article
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 1036, doi. 10.1002/ajh.24173
- By:
- Publication type:
- Article
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 566, doi. 10.1002/ajh.23454
- By:
- Publication type:
- Article
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 11, p. 1006, doi. 10.1002/ajh.23303
- By:
- Publication type:
- Article
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 459, doi. 10.1016/j.clml.2024.03.001
- By:
- Publication type:
- Article
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 355, doi. 10.1016/j.clml.2023.01.007
- By:
- Publication type:
- Article
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e521, doi. 10.1016/j.clml.2022.01.015
- By:
- Publication type:
- Article
Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e467, doi. 10.1016/j.clml.2022.01.002
- By:
- Publication type:
- Article
MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01826-7
- By:
- Publication type:
- Article
MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01825-5
- By:
- Publication type:
- Article
MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01801-2
- By:
- Publication type:
- Article
MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S341, doi. 10.1016/S2152-2650(21)01794-8
- By:
- Publication type:
- Article
AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S309, doi. 10.1016/S2152-2650(21)01733-X
- By:
- Publication type:
- Article
AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S293, doi. 10.1016/S2152-2650(21)01700-6
- By:
- Publication type:
- Article
Poster: MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01460-9
- By:
- Publication type:
- Article
Poster: MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01459-2
- By:
- Publication type:
- Article
Poster: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01433-6
- By:
- Publication type:
- Article
Poster: MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01428-2
- By:
- Publication type:
- Article
Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S214, doi. 10.1016/S2152-2650(21)01345-8
- By:
- Publication type:
- Article
Poster: AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S213, doi. 10.1016/S2152-2650(21)01340-9
- By:
- Publication type:
- Article
Oral Abstract: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01269-6
- By:
- Publication type:
- Article
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
- Published in:
- 2021
- By:
- Publication type:
- letter
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Defining Acute Myeloid Leukemia Ontogeny in Older Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ring Sideroblast Quantification is Highly Predictive of TP53 Mutation in MDS with Excessive Blasts with Prognostic Implications.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S344, doi. 10.1016/j.clml.2019.07.350
- By:
- Publication type:
- Article
Hypoplastic MDS in the Elderly: A Single Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.344
- By:
- Publication type:
- Article
Venetoclax Combination with Hypomethylating Agents for Treatment of Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S339, doi. 10.1016/j.clml.2019.07.340
- By:
- Publication type:
- Article
Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Obesity Impact on Outcomes of Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S262, doi. 10.1016/j.clml.2018.07.174
- By:
- Publication type:
- Article
Hypomethylating Agents Versus Intensive Chemotherapy in Older Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S201, doi. 10.1016/j.clml.2018.07.051
- By:
- Publication type:
- Article
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic Significance of Serial Molecular Annotation in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S344, doi. 10.1016/j.clml.2017.07.166
- By:
- Publication type:
- Article
Improved Responses with Azacitidine Compared to Decitabine in Patients with Acute Myeloid Leukemia in Patients ≥70 with Poor-Risk Cytogenetics.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S295, doi. 10.1016/j.clml.2017.07.085
- By:
- Publication type:
- Article
Monocytosis in myelofibrosis is associated with clinical outcome, hematologic abnormalities and somatic mutations.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S357, doi. 10.1016/j.clml.2017.07.188
- By:
- Publication type:
- Article
Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Myelodysplastic/Myeloproliferative Neoplasms Unclassified (MDS/MPN-U) Overlap: Impact of Hypomethylating Agents?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S96, doi. 10.1016/j.clml.2016.07.137
- By:
- Publication type:
- Article
Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of Over 600 Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S29, doi. 10.1016/j.clml.2016.07.042
- By:
- Publication type:
- Article
ASXL1 Frameshift Mutations Drive Inferior Outcomes in CMML without Negative Impact in MDS.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S87, doi. 10.1016/j.clml.2016.07.122
- By:
- Publication type:
- Article
Myelodysplastic Syndromes with Bone Marrow Fibrosis: a Distinct Entity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S85, doi. 10.1016/j.clml.2016.07.121
- By:
- Publication type:
- Article
Racial Disparities in Patients with Myelodysplastic Syndrome (MDS): is There Really a Difference?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S89, doi. 10.1016/j.clml.2016.07.126
- By:
- Publication type:
- Article